{"id":"https://openalex.org/W2005161393","doi":"https://doi.org/10.1097/01.shk.0000223305.35238.0c","title":"BASELINE SEVERITY OF SEPSIS IN SUBJECTS OF THE PROWESS AND THE KYBERSEPT CLINICAL TRIALS ON ENDOGENOUS ANTICOAGULANTS","display_name":"BASELINE SEVERITY OF SEPSIS IN SUBJECTS OF THE PROWESS AND THE KYBERSEPT CLINICAL TRIALS ON ENDOGENOUS ANTICOAGULANTS","alternate_titles":[],"publication_year":2006,"publication_date":"2006-05-22","ids":{"openalex":"https://openalex.org/W2005161393","doi":"https://doi.org/10.1097/01.shk.0000223305.35238.0c","mag":"2005161393","pmid":"https://pubmed.ncbi.nlm.nih.gov/16721275"},"language":"en","primary_location":{"id":"doi:10.1097/01.shk.0000223305.35238.0c","doi":"https://doi.org/10.1097/01.shk.0000223305.35238.0c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.shk.0000223305.35238.0c","pdf_url":null,"source":{"id":"https://openalex.org/S174819509","display_name":"Shock","issn_l":"1073-2322","issn":["1073-2322","1540-0514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SHOCK","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005161393"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056872170","display_name":"Christian Josef Wiedermann","orcid":"https://orcid.org/0000-0002-4639-8195","observed_orcids":["https://orcid.org/0000-0002-4639-8195"]},"institutions":[{"id":"https://openalex.org/I4210091033","display_name":"Ospedale di Bolzano","ror":"https://ror.org/00cmk4n56","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091033"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Christian J. Wiedermann","raw_affiliation_strings":["Department of Internal Medicine, Central Hospital of Bolzano, Bolzano (BZ), Italy. Christian.Wiedermann@asbz.i","Department of Internal Medicine, Central Hospital of Bolzano, Bolzano (BZ), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Central Hospital of Bolzano, Bolzano (BZ), Italy. Christian.Wiedermann@asbz.i","institution_ids":["https://openalex.org/I4210091033"]},{"raw_affiliation_string":"Department of Internal Medicine, Central Hospital of Bolzano, Bolzano (BZ), Italy","institution_ids":["https://openalex.org/I4210091033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085173138","display_name":"Heinz-Otto Keinecke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155390","display_name":"CSL (Germany)","ror":"https://ror.org/04nvba109","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I4210155390"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heinz-Otto Keinecke","raw_affiliation_strings":["Accovion GmbH, Marburg/Lahn, Germany, and","Accovion GmbH, Marburg/Lahn, Germany, and \u2021ZLB Behring, Hattersheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Accovion GmbH, Marburg/Lahn, Germany, and","institution_ids":[]},{"raw_affiliation_string":"Accovion GmbH, Marburg/Lahn, Germany, and \u2021ZLB Behring, Hattersheim, Germany","institution_ids":["https://openalex.org/I4210155390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098013746","display_name":"Mathias J rs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155390","display_name":"CSL (Germany)","ror":"https://ror.org/04nvba109","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210153402","https://openalex.org/I4210155390"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Mathias J??rs","raw_affiliation_strings":["ZLB Behring, Hattersheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ZLB Behring, Hattersheim, Germany","institution_ids":["https://openalex.org/I4210155390"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111630320","display_name":"Steve M. Opal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800446032","display_name":"Rhode Island Hospital","ror":"https://ror.org/01aw9fv09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800446032","https://openalex.org/I4210151747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve M. Opal","raw_affiliation_strings":["Infectious Disease Division, Rhode Island Hospital, Providence, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Division, Rhode Island Hospital, Providence, RI","institution_ids":["https://openalex.org/I2800446032"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5056872170"],"corresponding_institution_ids":["https://openalex.org/I4210091033"],"apc_list":null,"apc_paid":null,"fwci":1.1889,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.81996166,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"6","first_page":"657","last_page":"658"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/severe-sepsis","display_name":"severe sepsis","score":0.8799999952316284},{"id":"https://openalex.org/keywords/baseline-disease-severity","display_name":"baseline disease severity","score":0.8629999756813049},{"id":"https://openalex.org/keywords/prowess-trial","display_name":"PROWESS trial","score":0.8700000047683716},{"id":"https://openalex.org/keywords/recombinant-activated-protein-c","display_name":"recombinant activated protein C","score":0.9639999866485596},{"id":"https://openalex.org/keywords/mortality-prediction","display_name":"mortality prediction","score":0.5879999995231628},{"id":"https://openalex.org/keywords/saps-ii","display_name":"SAPS II","score":0.7749999761581421},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.703000009059906},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.5429999828338623},{"id":"https://openalex.org/keywords/sepsis-mortality","display_name":"sepsis mortality","score":0.4099999964237213},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8675705790519714},{"id":"https://openalex.org/C147021879","wikidata":"https://www.wikidata.org/wiki/Q3027971","display_name":"Decile","level":2,"score":0.7329132556915283},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.6513552665710449},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6229289770126343},{"id":"https://openalex.org/C2779026020","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombin","level":3,"score":0.6200354099273682},{"id":"https://openalex.org/C2778005785","wikidata":"https://www.wikidata.org/wiki/Q412888","display_name":"Drotrecogin alfa","level":5,"score":0.5373164415359497},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5156573057174683},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4851273000240326},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.47860854864120483},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.4278743267059326},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41079550981521606},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.40105515718460083},{"id":"https://openalex.org/C2994086866","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Severe sepsis","level":4,"score":0.2520381808280945},{"id":"https://openalex.org/C2777628635","wikidata":"https://www.wikidata.org/wiki/Q1765564","display_name":"Septic shock","level":3,"score":0.13670077919960022},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011486","descriptor_name":"Protein C","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.shk.0000223305.35238.0c","doi":"https://doi.org/10.1097/01.shk.0000223305.35238.0c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.shk.0000223305.35238.0c","pdf_url":null,"source":{"id":"https://openalex.org/S174819509","display_name":"Shock","issn_l":"1073-2322","issn":["1073-2322","1540-0514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SHOCK","raw_type":"journal-article"},{"id":"pmid:16721275","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16721275","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Shock (Augusta, Ga.)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1975961976","https://openalex.org/W2032947392","https://openalex.org/W2036333900","https://openalex.org/W2036700071","https://openalex.org/W2048933053","https://openalex.org/W2154611259","https://openalex.org/W4249401890"],"related_works":["https://openalex.org/W2071041464","https://openalex.org/W2968641284","https://openalex.org/W4323268194","https://openalex.org/W4386430510","https://openalex.org/W2163101729","https://openalex.org/W1856983313","https://openalex.org/W2782604865","https://openalex.org/W2611945296","https://openalex.org/W2201030059"],"abstract_inverted_index":{"Anticoagulants":[0],"may":[1,499],"provide":[2],"survival":[3],"benefit":[4,507],"when":[5],"used":[6],"as":[7,64],"adjunctive":[8],"therapy":[9],"in":[10,41,55,75,99,105,156,162,165,177,217,228,293,309,352,386,418,433,445,479,489,535],"severe":[11,42,85,493],"sepsis":[12,135,307,494,541],"if":[13],"targeted":[14],"to":[15,78,81,254,377,420,436,454,458,508],"patients":[16,82,136,176,216,273,384],"with":[17,83,188,246,276,347,350,368,406,427,430],"high":[18,248,390],"risk":[19,249,278,283,355,361,391,448],"of":[20,50,52,96,134,171,174,186,207,215,223,250,272,279,284,316,326,356,362,383,392,411,449,452,473,484,487,492,506,515,523,547],"mortality":[21,173,190,209,222,337,343,357,363,393,416,424,440,450],"from":[22,35,150,261,267,511],"this":[23,230,464,524,551],"disease":[24,51,333],"(1).":[25],"In":[26],"their":[27],"recent":[28,480],"article":[29],"entitled":[30],"\"What":[31],"can":[32],"we":[33],"learn":[34],"the":[36,94,100,106,109,122,157,178,184,198,204,241,262,268,294,310,324,369,381,387,434,446,476,485,490,502,512,536,556],"three":[37],"megatrials":[38],"using":[39],"anticoagulants":[40,488],"sepsis?,\"":[43],"Iba":[44],"and":[45,67,193,298,359,400,456],"Kidokoro":[46],"(2)":[47],"compared":[48,275,349,429],"severity":[49,123,133,334,498],"subjects":[53],"enrolled":[54,385],"PROWESS":[56,76,141,163,218,295,371],"that":[57,69,90,114,182,238,380,542],"had":[58,219],"recombinant":[59,257,327,516,531],"human":[60],"activated":[61,258,328,517,532],"protein":[62,259,329,518,533],"C":[63,260,330,519,534],"study":[65,234],"drug":[66],"KyberSept":[68,229,311,412,474],"studied":[70],"high-dose":[71],"antithrombin.":[72,521],"Benefits":[73],"observed":[74,346,426],"appeared":[77],"be":[79,117,404,500,509],"restricted":[80],"more":[84,468],"illness":[86],"(3).":[87,470],"The":[88,143,167,339],"observation":[89],"antithrombin":[91],"did":[92],"show":[93],"trend":[95],"favorable":[97],"outcome":[98],"high-risk":[101,111,558],"group":[102,231,559],"but":[103,439],"not":[104],"low":[107],"or":[108,341,520],"very":[110,247,389,398,557],"groups":[112,159],"indicates":[113,181,237],"there":[115],"should":[116],"a":[118,220,313],"proper":[119],"window":[120],"regarding":[121,240],"for":[124,140,256,306,414,530,555],"each":[125],"agent":[126],"(2,":[127],"4).":[128],"Detailed":[129],"data":[130,149,263,472],"on":[131,288,299,323,332,539],"baseline":[132],"have":[137],"been":[138,527],"published":[139],"(5).":[142],"present":[144],"communication":[145],"formally":[146],"reports":[147],"such":[148],"KyberSept.":[151,166],"Mortality":[152],"at":[153],"28":[154],"days":[155],"placebo":[158,351,431],"was":[160,195,286,397,425,543],"lower":[161,342,422],"than":[164,225],"comparison":[168],"by":[169,335],"deciles":[170,206],"predicted":[172,189,208,221,277,336,354,360,388,447],"all":[175,353],"2":[179],"studies":[180,199],"only":[183,213,432],"number":[185,382],"patient":[187,243],"between":[191,197],"30%":[192,435,455],"40%":[194],"comparable":[196],"(Fig.":[200],"1).":[201],"Recruitment":[202],"into":[203],"other":[205],"differed.":[210],"Most":[211],"importantly,":[212],"9%":[214],"higher":[224,444],"60%,":[226],"whereas":[227],"comprised":[232],"28%":[233],"subjects.":[235],"This":[236],"conclusions":[239,402,477],"sickest":[242],"population,":[244],"those":[245],"death,":[251],"are":[252],"difficult":[253],"draw":[255,478],"available":[264],"so":[265],"far":[266],"trials.Fig.":[269],"1:":[270],"Frequency":[271],"(%)":[274],"mortality.":[280],"Predicted":[281],"underlying":[282],"death":[285],"based":[287],"multiple":[289],"logistic":[290],"regression":[291],"analysis":[292,315,410],"trial":[296,538],"(5)":[297,321],"Simplified":[300],"Acute":[301],"Physiology":[302],"Score":[303],"II":[304],"customized":[305],"(6)":[308],"trial.In":[312],"subgroup":[314,364],"PROWESS,":[317,421],"Ely":[318],"et":[319],"al.":[320],"reported":[322],"efficacy":[325],"depending":[331],"deciles.":[338,460],"same":[340],"rates":[344,441],"were":[345,366,442],"treatment":[348,428,491],"classes,":[358],"results":[365,372],"consistent":[367],"overall":[370],"(4).":[373],"It":[374],"is":[375,552],"important":[376,504],"note,":[378],"however,":[379],"classes":[394],"(i.e.,":[395],">60%)":[396],"low,":[399],"therefore,":[401],"must":[403],"drawn":[405],"caution.":[407],"A":[408],"similar":[409],"shows":[413],"28-day":[415,423],"that,":[417],"contrast":[419],"60%":[437,457],"deciles,":[438],"nominally":[443],"subgroups":[451],"0%":[453],"100%":[459],"At":[461],"90":[462],"days,":[463],"notion":[465],"even":[466],"became":[467],"prominent":[469],"These":[471],"support":[475],"post":[481],"hoc":[482],"analyses":[483],"use":[486,514],"(1,":[495],"2).":[496],"Disease":[497],"among":[501],"most":[503],"predictors":[505],"derived":[510],"therapeutic":[513],"Part":[522],"hypothesis":[525],"has":[526],"recently":[528],"confirmed":[529],"ADDRESS":[537],"low-risk":[540],"prematurely":[544],"terminated":[545],"because":[546],"futility":[548],"(7).":[549],"Whether":[550],"also":[553],"true":[554],"awaits":[560],"further":[561],"study.":[562]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005161393","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
